Postsurgical Pain
Phase II studies to be initiated with APF112
Published in Medical Devices and Surgical Technology Week, September 28th, 2003
In July, the company submitted a comprehensive data package to the U.S. Food and Drug Administration (FDA) that included a proposed phase II protocol. Following a review with FDA officials, the company was given clearance to initiate the proposed clinical study. The company intends to initiate phase II trials with APF112 in September 2003 for the treatment of pain in patients following repair of inguinal hernia.
APF112 incorporates mepivacaine, a local anesthetic with analgesic properties, which has been used extensively in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Enlarged Prostate
Study proves long-term durability of TUNA therapy - Medical Devices
Residual ethylene oxide varies in medical devices and device material - Skin Cancer
Multispectral polarized light imaging helps guide tumor excision surgery - Total Hip Arthroplasty
Metal-on-metal bearings dislocate less than ceramic-on-polyethylene bearings - Tumor Characterization
MRI can serve as noninvasive tool for characterizing regions of tumors - AIDS Testing
VScan HIV test kits being shipped to the Congo - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
